Valar Labs
Palo Alto, US · Founded 2021 · Delaware corporation · 5 known investors
Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.
Founders & leadership
AJ

Anirudh JoshiCo-founder & CEO30 Under 30 2025
VK

Viswesh KrishnaCo-founder & CTO30 Under 30 2025
DV
Damir VrabacExecutive Officer, Director
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$4.1MraisedApr 2022 · 19 investors · OtherRule 506(b)
▶$4.1MraisedApr 2022 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Anirudh Rajiv JoshiExecutive Officer, Director
- Damir VrabacExecutive Officer, Director
- Viswesh KrishnaExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Valar Labs: Computational Cancer Therapy AI Company Raises $22 Millionpulse2.com · 2024
- Valar Labs Raises $22M in Series A Fundingfinsmes.com · 2024
- Valar Labs Funding: $22.0M | Complete Analysis | Extruct AIextruct.ai